Glaukos Stock Surges After FDA iDose Approval - Orange County Business Journal

Glaukos, founded in 1998, pioneered the now well-established microinvasive glaucoma surgery (MIGS) marketplace. Its best-known product is the iStent, which is among the smallest medical devices ever made.

Related Keywords

Ireland ,Tomas Navratil ,Tom Burns ,Michael Sarcone ,Drug Administration ,Aliso Glaukos Corp ,Aliso Viejo Based Glaukos ,Chief Executive Tom Burns ,Chief Development Officer Tomas Navratil ,